2019 Speakers

 

Nabil Al Humadi, Pharmacologist And Toxicologist, Food and Drug Administration (FDA)

Dr M. Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Sina Bavari, Chief of Molecular and Translational Sciences, U.S. Army Medical Research Institute of Infectious Diseases

Sean Bennett, Senior Director Of Clinical Development And Medical Affairs, Emergent BioSolutions

Sean Bennett | Senior Director Of Clinical Development And Medical Affairs | Emergent BioSolutions » speaking at Vaccine West Coast

Praveen Bommareddy, Lead, Replimune

Praveen Bommareddy | Lead | Replimune » speaking at Vaccine West Coast

Darrick Carter, Vice President - Adjuvant Technology, I.D.R.I.

Dr Rachel Clemens, Commercial Innovation Manager, Center for the Advancement of Science In Space

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Dr Rajeev Dadoo, Partner, S.R. One

Tom Davis, CMO, Genocea Biosciences

Daryl Drummond, Senior Vice President And Head Of Research, Merrimack Pharmaceuticals

Dr Roland Dunbrack, Professor, Fox Chase Cancer Center

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Dr Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Dr Evanthia Galanis, Professor, Chair Molecular Medicine, Mayo Clinic

Dr Hanspeter Gerber, SVP & CSO, 3T Biosciences

Wouter Hazenbos, Scientist, Genentech

Charles Heffernan, Former Supply Chain Transformation And Technology Innovation Lead, Gsk And Member, BioPhorum Operations Group

Charles Heffernan | Former Supply Chain Transformation And Technology Innovation Lead, Gsk And Member | BioPhorum Operations Group » speaking at Vaccine West Coast

Priti Hegde, Director and Global Franchise Lead, Genentech

Dr Robert Hollingsworth, Vice-President & CSO, Cancer Vaccines & Immunotherapeutics, Pfizer

Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children?S Hospital Center, Baylor College of Medicine

Beckie Ingram, Senior Lecturer/ PI, QUB

Hasan Jafri, Senior Director, Clinical Research and Development, Infectious Disease and Vaccines, MedImmune Inc

Kathrin Jansen, Senior Vice President And Chief Scientific Officer, Pfizer

Kathrin Jansen | Senior Vice President And Chief Scientific Officer | Pfizer » speaking at Vaccine West Coast

Dr Joseph Jardine, Head Of Antibody Discovery, Institute For Protein Innovation

Dr Maria Karasarides, Executive Director, Immunooncology, Regeneron Pharmaceuticals

Dr Pravin Kaumaya, Professor, Ohio State University

Kevin Killeen, Chief Scientific Officer, Matrivax

Dr Chet Kitchen, Cancer Patient Advocate, Merck & Co Inc

Steven Kleiboeker, Vice-President, Research And Development, Viracor Eurofins

Dr Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Alexander Koglin, Co-Founder, Chief Science and Technology Officer, NTxBio

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience GmbH

Dr Andrew Lees, Scientific Director, Fina BioSolutions

Ofer Levy, Professor Of Pediatrics, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Dr Sumithra Mandrekar, Professor Of Biostatistics And Oncology, Mayo Clinic

Dr Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc

Justin Moran, Senior Bioprocess Development Director, Pfizer

Michael Murray, Analyst, Biotechnology Value Fund

Duncan Mwangi, Research Director, Zoetis

Dr Susan Old, Deputy Director of the Division of Extramural Activities, NIAID

Dr Susan Old | Deputy Director of the Division of Extramural Activities | NIAID » speaking at Vaccine West Coast

Sukhmani Padda, Assistant Professor, Stanford Cancer Institute

Sukhmani Padda | Assistant Professor | Stanford Cancer Institute » speaking at Vaccine West Coast

Dr Grant Pickering, Chief Executive Officer, SutroVax, Inc

Clemencia Pinilla, Associate Member, Torrey Pines Institute for Molecular Studies

Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen

Mary Jo Potter, Founder And Chief Executive Officer, Healthcare Angels

Bali Pulendran, Department of Pathology, Microbiology&Immunology, Stanford University School of Medicine

Dr Steven Reed, Founder, Distinguished Scientist, Infectious Disease Research Institute

Dr Raphael Rousseau, Executive Vice President And Head Of Product Development And Chief Medical Officer, Gritstone Oncology

Sarah Royalty Tredo, Director, Emergent Biosolutions

Naik Rumi Armaghan, Director and Head, Sanofi Pasteur

Helen Sabzevari, President, Precigen

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Richard Scheuermann, Director, J Craig Venter Institute

Dr Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Dr Alessandro Sette, Professor, Head and Member, La Jolla Infectious Disease Institute

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, Merck

Dr Gary Starling, Associate Vice President, Discovery Biologics, Merck

Dr Lesley Stolz, Head Of JLABS Bay Area, Johnson & Johnson Innovation

Nancy Sullivan, Chief And Biodefense Research Section, Vaccine Research Center, National Institutes of Health

Jun Tang, Senior Manager Philanthropic Venture Fund And Clinical Accelerator, Cancer Research Institute

Dr Raymond Tesi, Chief Executive Officer, INmune Bio

Dr Sangeeta Tiwari, Associate (faculty), Albert Einstein College of Medicine

Dr Steven Townson, Oncology Scientific Director, Principal Scientist, Clinical Research Oncology Early Development, Merck Research Laboratories

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Chia-Wei Tsai, Branch Chief, BARDA

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Louis-Philippe Vezina, CEO, Angany

Kalpit Vora, Director, Merck And Company

Prof Ignasio Wistuba, Professor and Chairman, The University of Texas MD Anderson Cancer Center

Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.

 

DOWNLOAD PROSPECTUS

 

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156

oliver.breed@terrapinn.com


To speak:
Lauren Sheppard
+44 (0)207 092 1211

lauren.sheppard@terrapinn.com